1[1]Block GA,Hulbert-Shearon TE,Levin NW et al.Association of serum phosphorus and calcium×phosphate product with mortality risk in chronic hemodialysis patients;a national study.Am J Kidney Dis,1998,31:607
2[2]Levin NW,Hulbest-Shearon TE,Strawdesman RL et al.Which causes of death are related to hyperphatemia in hemodialysis patients?J Am Soc Nephrol,1998,9:217A
3[3]Braun J,Oldendorf M,Moshage W et al.Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.Am J Kidney Dis,1996,27:394
4[4]Goodman WG,Goldin J,Kuizon BD et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.N Engl J Med,2000,342:1478
5[5]Slatopolsky E,Brown A,Dusso A.Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.Am J Kidney Dis,2001,37:(Suppl 2):S54
6[6]Bleyer AJ,Burke S,Dillon M et al.A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients.Am J Kidney Dis,1999,33:694
7[7]Chertow G,Burke S,Dillon M et al.Long-term effects of sevelamer hydrochloride on the calcium×phosphate product and lipid profile of haemodialysis patients.Nephrol Dial Transplant,1999,14:2907
8[8]Raggi P,Burke S,Dillon M et al.Sevelamer attenuates the progression of coronary and aortic calcification compared with cacium-based phosphate binders [abstract].J Am Soc Nephrol,2001,12:A1232
9[9]Burke S,Amin N,Incerti C et al.Sevelamer hydrochloride (Renagel),a nonabsorbed phosphate-binding polymer,does not interfere with digoxin or warfarin pharmacokinetisc.J Clin Pharmacol,2001,41:193
10[10]Burke S,Amin N,Incerti C et al.Sevelamer hydrochloride (Renagel),a phosphate-binding polymer,does not alter the pharmacokinetics of two commonly used antihypertensives in healthy volunteers.J Clin Pharmacol,2001,41:199
